|
🦁
|
Selection criteria for lung-cancer screening.
11 auth.
M. Tammemägi,
H. Katki,
W. Hocking,
T. Church,
N. Caporaso,
P. Kvale,
...
A. Chaturvedi,
G. Silvestri,
T. Riley,
J. Commins,
C. Berg
|
9 |
2013 |
9
🦁
|
|
🐜
|
Overdiagnosis in low-dose computed tomography screening for lung cancer.
9 auth.
E. Patz,
P. Pinsky,
C. Gatsonis,
Jorean D. Sicks,
B. Kramer,
M. Tammemägi,
...
C. Chiles,
W. Black,
D. Aberle
|
9 |
2014 |
9
🐜
|
|
🦁
|
Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
8 auth.
M. Tammemägi,
T. Church,
W. Hocking,
G. Silvestri,
P. Kvale,
T. Riley,
...
J. Commins,
C. Berg
|
8 |
2014 |
8
🦁
|
|
🐜
|
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study
10 auth.
K. ten Haaf,
Jihyoun Jeon,
M. Tammemägi,
Summer S. Han,
C. Kong,
S. Plevritis,
...
E. Feuer,
H. D. de Koning,
E. Steyerberg,
R. Meza
|
7 |
2017 |
7
🐜
|
|
🦁
|
Impact of lung cancer screening results on smoking cessation.
M. Tammemägi,
C. Berg,
T. Riley,
Christopher Cunningham,
K. Taylor
|
7 |
2014 |
7
🦁
|
|
🐜
|
Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada
9 auth.
K. ten Haaf,
M. Tammemägi,
S. Bondy,
C. van der Aalst,
S. Gu,
S. Elizabeth McGregor,
...
G. Nicholas,
H. D. de Koning,
L. Paszat
|
6 |
2017 |
6
🐜
|
|
🐜
|
The Cost‐Effectiveness of High‐Risk Lung Cancer Screening and Drivers of Program Efficiency
39 auth.
S. Cressman,
S. Peacock,
M. Tammemägi,
W. Evans,
N. Leighl,
J. Goffin,
A. Tremblay,
Geoffrey Liu,
D. Manos,
P. MacEachern,
Rick Bhatia,
S. Puksa,
G. Nicholas,
A. Mcwilliams,
J. Mayo,
...
J. Yee,
J. English,
R. Pataky,
Emily McPherson,
S. Atkar‐Khattra,
M. Johnston,
Heidi Schmidt,
F. Shepherd,
Kam Soghrati,
K. Amjadi,
P. Burrowes,
C. Couture,
H. Sekhon,
K. Yasufuku,
G. Goss,
D. Ionescu,
D. Hwang,
S. Martel,
D. Sin,
W. Tan,
S. Urbanski,
Zhaolin Xu,
M. Tsao,
S. Lam
|
6 |
2017 |
6
🐜
|
|
🐜
|
Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study
15 auth.
M. Walker,
Olivia Meggetto,
Julia Gao,
Gabriela Espino-Hernández,
N. Jembere,
C. Bravo,
Michelle Rey,
U. Aslam,
A. Sheppard,
A. Lofters,
...
M. Tammemägi,
J. Tinmouth,
R. Kupets,
A. Chiarelli,
L. Rabeneck
|
6 |
2021 |
6
🐜
|
|
🦁
|
Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers.
M. Tammemägi,
John R. McLaughlin,
Shelley B. Bull
|
6 |
1999 |
6
🦁
|
|
🦁
|
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study
42 auth.
M. Tammemägi,
M. Ruparel,
A. Tremblay,
R. Myers,
J. Mayo,
J. Yee,
S. Atkar‐Khattra,
R. Yuan,
S. Cressman,
J. English,
E. Bédard,
P. MacEachern,
P. Burrowes,
S. Quaife,
H. Marshall,
...
I. Yang,
R. Bowman,
Linda H. Passmore,
A. Mcwilliams,
F. Brims,
K. Lim,
Lin Mo,
S. Melsom,
B. Saffar,
M. Teh,
R. Sheehan,
Y. Kuok,
R. Manser,
L. Irving,
Daniel P Steinfort,
M. McCusker,
D. Pascoe,
P. Fogarty,
E. Stone,
D. C. Lam,
M. Ng,
V. Vardhanabhuti,
C. Berg,
R. Hung,
S. Janes,
K. Fong,
S. Lam
|
6 |
2021 |
6
🦁
|
|
🐜
|
Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation.
13 auth.
J. Sands,
M. Tammemägi,
S. Couraud,
D. Baldwin,
A. Borondy-Kitts,
D. Yankelevitz,
Jennifer A. Lewis,
F. Grannis,
H. Kauczor,
Oyunbileg von Stackelberg,
...
L. Sequist,
U. Pastorino,
Brady J. McKee
|
6 |
2020 |
6
🐜
|
